RhumbLine Advisers’s Achieve Life Sciences ACHV Stock Holding History

RhumbLine Advisers’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$568K	Buy	+87,023	New	+$415K	﹤0.01%	2682
2025 Q2	–	Sell	-42,267	Closed	-$113K	–	4140
2025 Q1	$113K	Buy	42,267 +1,497	+4%	+$4.66K	﹤0.01%	3352
2024 Q4	$144K	Sell	40,770 -196	-0.5%	-$888	﹤0.01%	3357
2024 Q3	$194K	Sell	40,966 -852	-2%	-$3.89K	﹤0.01%	3258
2024 Q2	$197K	Buy	+41,818	New	+$201K	﹤0.01%	3232
2014 Q2	–	Sell	-6	Closed	-$148K	–	3008
2014 Q1	$148K	Hold	6	–	–	﹤0.01%	2859
2013 Q4	$111K	Hold	6	–	–	﹤0.01%	2946
2013 Q3	$123K	Hold	6	–	–	﹤0.01%	2908
2013 Q2	$132K	Buy	+6	New	+$134K	﹤0.01%	3169

Other funds holding ACHV

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

RhumbLine Advisers's ACHV Position: Q2 2026 in Review

RhumbLine Advisers opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 87,023 shares worth $568K. The stake represents ﹤0.01% of the portfolio and ranks #2682 among its holdings. This is a return to the name: RhumbLine Advisers previously reported a position in ACHV as recently as Q1 2025.

RhumbLine Advisers first reported a position in ACHV in Q2 2013 and has held it in 9 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

RhumbLine Advisers held 87,023 shares of Achieve Life Sciences worth $568K as of Q2 2026.
Achieve Life Sciences was a new RhumbLine Advisers position in Q2 2026.
Achieve Life Sciences made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2682 holding.
RhumbLine Advisers first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 9 quarters since.
111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.